Form 4 Filing for Evommune, Inc.

Luis C. Pena, President & CEO and Director of Evommune, Inc., acquired 1115 shares of common stock on September 30, 2026, under the company's Employee Stock Purchase Plan. The shares were purchased at a discounted price of $7.02 per share, representing 85% of the closing price on the transaction date. This acquisition brings Mr. Pena's total post-transaction shares to 631,573. The filing was submitted late due to an administrative oversight. The transaction code "A" indicates an acquisition of securities.